Website Information
    Web Site Information :.   Site Info    Whois    Traceroute    RBL Check  

Enter Web Site URL Address:
 

eucarbon.at: Eucarbon bei Reizdarmsyndrom : irritable bowel syndrome
 
 
 

Eucarbon bei Reizdarmsyndrom : irritable bowel syndrome

Tags: eucarbon, syndrome, bowel, irritable, bei, reizdarmsyndrom, spanish, arabic, thai, turkish, ukrainian, lithuanian, slovakian, roumanian, russian, portuguese, hebrew, corean, bulgarian, albanian, estonian, georgian, indonesian, hungarian, kazakhstanian,

Eucarbon.at

Content Revalency: Title: 0.00%   Description: 0.00%   Keywords: 0.00%  |  Document size: 8,777 bytes
More info: Whois - Trace Route - RBL Check
 
DMOZ Information
Trenka Chem.-pharm. Fabrik Ges.m.b.H.
Die Firma vertreibt vor allem das Medikament Eucarbon, welches bei Verdauungsbeschwerden eingesetzt wird. [A-1040 Wien]

Top/World/Deutsch/Wirtschaft/Pharma_und_Biotechnologie/Pharmazeutika
http://www.eucarbon.at/

Eucarbon.at has 1 URLs listed in 1 Dmoz categories.

Related Sites:   Alconlabs.com , Apogepha.de , Astrazeneca.ch , Astrazeneca.de , Aventis.at , Basics.de , Bastian-werk.de , Boehringer-ingelheim.de , Essex.de , Eisai.de ,
 
EUCARBON.AT - Site Location
Country/Flag AT Austria
City/Region/Zip Code , ,
Organization UPC Austria GmbH
Internet Service Provider UPC Austria GmbH
 
EUCARBON.AT - Domain Information
Domain eucarbon.at   [ Traceroute  RBL/DNSBL lookup ]
Whois server whois.nic.at
Created --
Updated --
Expires --
Time Left 0 days 0 hours 0 minutes
DNS servers ns1.easyname.eu   77.244.243.4
ns2.easyname.eu   194.88.216.9
 
EUCARBON.AT - DNS Information
IP Address 85.126.116.179 ~ Whois - Trace Route - RBL Check
Domain Name Servers ns1.domainname.at   168.119.46.69
ns2.domainname.at   51.195.125.207
Mail Exchange mail.eucarbon.at  
 
Site Response Header
Response HTTP/1.1 200 OK
Server Apache/2.2.9 (Debian) PHP/5.2.6-1+lenny9 with Suhosin-Patch
Date Mon, 11 Apr 2011 08:29:08 GMT
Content-Type text/html


  IP Index    TLD Index    Domain Index    Site Index New   Copyright © 2025 Cybernet Quest.